Call button

Drug Recalls & Market Withdrawals

A look inside prescription drugs and why they get removed from the market All medications released for public use must be approved by the United States Food and Drug Administration. In most cases, the drug goes through a rigorous testing process to insure that it is safe for the public. However, there have been cases … Read more

CDC: Opioid pain relievers may increase risk for certain birth defects

  Moms and Dads, please read this warning about drugs like Oxy and other opoids. The Los Angeles Times “Booster Shots” blog (3/2, Maugh II) reported, “Consuming opioid pain relievers such as codeine, oxycodone or hydrocodone just before pregnancy or early in pregnancy increases the risk of certain birth defects, especially congenital heart defects,” according … Read more

Two studies suggest diabetes drug Avandia increases risk of heart problems.

If you suffer from diabetes, you need to read this. ABC World News (6/28, story 7, 2:20, Sawyer) reported, “Two major studies have found the medicine called Avandia [rosiglitazone] could create a significant new risk of heart attack and other serious problems.” The Washington Post (6/29, Stein) reports that one study, “involving more than 35,500 … Read more

LATimes examines suspected risks of bisphosphonates

If you take drugs for osteoporosis, read this… The Los Angeles Times (3/22, Adams) reports, “Long-term use of osteoporosis drugs seems to change bones in a way that could lead to unusual leg fractures, according to two reports presented earlier this month at a meeting of orthopedic surgeons. Doctors have reported seeing the unusual fractures … Read more

Avandia Drug Injury Discussed In New Senate Report

  In a front-page story, the New York Times (2/20, A1, Harris) reported, “Hundreds of people taking Avandia [rosiglitazone], a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports.” A Senate Finance Committee review cites internal FDA documents that highlight a dispute among regulators that “has been … Read more